Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Industry,Science & Environment
August 23, 2026
A new clinical scoring system, the Seven-Up score, helps identify which liver transplant patients truly require treatment for early rejection. By combining standard day-seven biopsy results with specific blood marker trends, researchers found that most early signs of rejection resolve spontaneously.
Currently, medical teams often rely solely on biopsy histology, which can lead to over-treatment with steroids. The new study indicates that relying on biopsy findings alone subjects patients to unnecessary risks, including infections and metabolic issues, without improving long-term graft survival.
In a study of 421 patients, the Seven-Up score prevented over 30% of recipients from receiving unnecessary steroid pulses. The data confirms that patients who were not treated based on this score achieved the same survival outcomes as those who received conventional care.
This research aligns with a growing movement in transplant medicine to move away from intensive, blanket immunosuppression protocols. Historically, the clinical approach has been overly cautious, often prioritizing the avoidance of graft loss at the expense of significant long-term patient health complications.
By shifting toward a more personalized, bio-histological diagnostic framework, medical centers can better manage the balance between protecting the new organ and minimizing the side effects of chronic steroid use. This transition reflects a broader industry shift toward precision medicine that favors objective, multi-factor assessments over singular diagnostic tests.